Previous Articles     Next Articles

Cold atmospheric plasma-activated medium selectively inhibits triple negative breast cancer cells

  

  1. 1. National Engineering Laboratory for Cereal Fermentation Technology, Jiangnan University, Wuxi 214122; 2. The Key Laboratory of Industrial Biotechnology, Ministry of Education, School of Biotechnology, Jiangnan University, Wuxi 214122; 3. Engineering Research Center of IoT Technology Applications, Jiangnan University, Wuxi 214122;4. Department of Oncology, Affiliated Hospital of Jiangnan University, Wuxi 214062, China
  • Online:2019-06-18 Published:2019-06-18

Abstract: Cold atmospheric plasma(CAP) has become a promising onco-therapeutic approach in recent years. Triple negative breast cancer is most aggressive among various breast cancer subtypes and has worst prognosis due to lack of effective therapy. We found that plasma-activated medium(PAM) selectively inhibited the proliferation and migration of triple negative breast cancer cells while causing little effect on other subtypes, and PAM selectively inhibited the phosphorylation of JNK in MDAMB231. We suggested that it was the more genome mutation and hyper-activated MAPK/JNK pathway in triple negative breast cancer cells that made them more sensitive to CAP. Our work revealed the relation between CAP and breast cancer subtypes and provides a preliminary basis for exploring the mechanism of CAP selectively killing triple negative breast cancer cells. 

Key words: cold atmospheric plasma, breast cancer, cell apoptosis, cell migration, JNK

CLC Number: